PharScite

PharScite

Pharmaceutical Technology

  • Home
  • Services
  • Courses
  • Events
  • Blog
  • News
  • Contact

Generic Drugs

Home Generic Drugs
ADHD Generics

First Generic of Strattera for the Treatment of ADHD Approved

By Sharif AhmedGeneric Drugs
Apotex, Teva, Aurobindo and Glenmark today gained approval to market atomoxetine in multiple strengths. Kathleen Uhl, M.D., director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research said “Quickly bringing generics to market so patients have more options to treat their conditions is a top…
1 Blue Hill Plaza, Suite 1509
Pearl River, New York 10965

Phone: +1 845-675-8540
Fax: +1 845-203-1495
Professional Development
Information Technology Solutions
Regulatory Services
Regulatory Insight
Regulatory Updates
Popular Courses
Upcoming Events

Subscribe to our RegLog and receive latest blog posts.
  • facebook
  • twitter
  • linkedin-square
  • instagram
  • youtube-play
Copyright © 2019 PharScite, LLC. All Right Reserved.
  • Terms
  • Privacy
  • Policy
  • Careers
✕
  • Home
  • Services
  • Courses
  • Events
  • Blog
  • News
  • Contact